Case Study | May 05, 2011

RFID Aids Radiation Therapy Patient Identification

May 5, 2011 – At the 2011 European Society for Therapeutic Radiology and Oncology (ESTRO) exhibition at the ExCel Centre in London, Elekta will demonstrate advanced solutions that provide clinicians with the tools to save and improve lives of cancer patients worldwide. This includes Elekta's new RFID system, Identify, which is designed to increase staff confidence in the integrity of patient identification and set up.

Identify harnesses precision radiofrequency identification technology and will ensure the right patient is being treated at the right location and with the correct set up and equipment. Identify will feature complete integration with Elekta's Mosaiq Oncology Information System, enabling patient queuing, selection of patient details in monitoring of set-up position, optimizing workflow and enhancing safety. Identify will be a scalable solution – from the treatment room to the entire department – allowing centers to grow as needs change.

Throughout the five major solution areas at the Elekta booth, the company will demonstrate how its digital platforms offer robust upgrade paths to accommodate a wide range of clinical requirements. The solution areas are:
Secure Workflow – personalized efficiency
Stereotaxy – premium solutions for the most challenging cases
Delivery – clinically focused, digitally controlled
Imaging – inspiring clinical confidence
Quality Assurance – completing the picture

In addition, Elekta will host a lunch symposium titled Throughput with Confidence on Monday, May 9 at the Capital Suites. The symposium will feature presentations by notable experts in the field of radiation oncology:
Professor Frank Lohr, University Hospital, Mannheim, Germany: Efficient VMAT Planning and Delivery
Ben J. Mijnheer, Ph.D., NKI/AvL, Amsterdam, Netherlands: Experiences from AvL with EPID-based In-Vivo Dosimetry
PD Reinhart A. Sweeney, University Hospital, Wurzburg, Germany; Christian Hieronimi, Elekta: Identify - who, what, where and how. Now!

For more information: www.elekta.com

Related Content

The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty, according to a report in Radiology.

Getty Images

News | Radiation Oncology | September 21, 2021
September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatmen
Non-oncology doctors’ knowledge of oncology is frequently not up to date, with risks in the communication with patients  

Getty Images

News | Radiation Oncology | September 20, 2021
September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, me
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

Getty Images

News | Radiation Oncology | September 13, 2021
September 13, 2021 — At the opening press conference of the ...
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments

Getty Images

News | ASTRO | September 09, 2021
September 9, 2021 — The American Society for Radiation Oncology (AS...
Cedars-Sinai Cancer researchers have discovered that intestinal microorganisms help regulate anti-tumor immune responses to radiation treatments.

Getty Images

News | Radiation Therapy | September 01, 2021
September 1, 2021 — The study, published on Aug.